SBIR Banner

You are here

NCI SBIR PLAN Webinar 5: How To Write a Strong Phase II Proposal

NCI SBIR Peer Learning and Networking (PLAN) Webinar 5: How to Write a Strong Phase II Proposal and Impress Reviewers

Tuesday, May 5, 2020, 1 - 2:30 p.m. ET



The goal of the NCI SBIR PLAN webinar series is to help SBIR-funded companies learn from their peers and encourage collaboration among awarded companies. This webinar will focus on three NCI-funded companies whose Phase II proposals scored extremely well (between 10-20), resulting in their project being funded. The current success rate for Phase II proposals at NCI is 25%; sharing insights, approaches, and lessons learned within the community is an effective way to support applicants by improving the quality of competitive applications. Three NCI SBIR/STTR awarded companies and Principal Investigators will participate in the webinar, specifically discussing their proposals and their approach in writing these excellent awarded Phase II grant applications.

After the first hour of the main webinar, each panelist will be available for further questions and discussions during breakout sessions. The breakout session web link will be available during the main webinar and will be a great place to get to know other SBIR awardees and discuss potential areas of collaboration with one another.

For more information about the webinar, please contact Patricia Swayne (


NCI SBIR PLAN Webinar:  How to Write a Strong Phase II Proposal and Impress Reviewers


Date: Tuesday, May 5, 2020 | 1:00 – 2:30 PM EDT



1:00 – 2:00 PM   Main webinar

  • Overview of Phase II Criteria and Expectations – Monique Pond, NCI SBIR Program Director
  • SBIR/STTR awarded companies share their experiences - Clarix Imaging, Enspectra Health, Modulation Therapeutics
  • Moderated Discussion with the panelists


2:00 – 2:30 PM   Breakout sessions with Gabriel Sanchez, Xiao Han, and Lori Hazlehurst


Moderator: Monique Pond, Program Director, NCI SBIR Development Center



Gabriel Sanchez, CEO & Co-Founder, Enspectra Health

Xiao Han, CEO, Clarix Imaging Corporation

Lori Hazlehurst, CEO & Co-Founder, Modulation Therapeutics